Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Sajid javid thanks pharmacies for delivering over 20 million Covid jabs

Health secretary Sajid Javid visited Medicine Chest Pharmacy in London on Friday (January 28) and thanked pharmacy teams across England for delivering well over 20 million Covid-19 jabs.

According to the latest research conducted by the National Pharmacy Association (NPA) and PharmData, independent community pharmacies were the biggest deliverers of Covid-19 vaccines during January 2021 to September 2021 as compared to corporate-run pharmacy sites.


As of January 2022, pharmacies across the whole sector had delivered 22 million Covid jabs, with the majority of them being independents of whom most are NPA members.

2new Sajid Javid standing outside Medicine Chest pharmacy in London.

In a video message released after the visit, Javid said: “Today I am here at Medicine Chest pharmacy in London to thank them, all pharmacies, the NHS, for the fantastic job they have done particularly over the last few months to get our country boosted. It’s because of this phenomenal success that today we are able to return to Plan A as we see Omicron in retreat and we learn to live with Covid.”

He said that after the success of vaccination programme “we’re able to announce a significant easing of restrictions on care homes” from Monday (January 31), and “will be significantly cutting self-isolation periods.”

Encouraging people to get vaccinated, he added, “please do come forward, get vaccinated, protect yourself and protect your community.”

NPA member Rohit Kotecha who runs Medicine Chest Pharmacy said: “We started Covid jabs in June 2021 and have vaccinated over 22,000 patients. We are open seven days a week and were vaccinating over Christmas and New Year to support the campaign to boost everyone this winter.

“It was good to have the health secretary visit to thank us for our work – it’s really important that politicians get a sense of what we do first hand.”

On decision to deliver Covid jabs, Andrew Hodgson, owner of Andrews Pharmacy in Macclesfield, said he always wanted to take on new services available for pharmacy “as services are the key to the future”.

Andrews Pharmacy is one of the first few community pharmacies to administer Covid-19 vaccines.

“We have a number of consultations rooms so we could get up and running at scale in a relatively short time.

“It was great for the nation and the world but it was good for the pharmacy too.”

Another NPA member, Olivier Picard, who runs the Newdays Pharmacy group, established the Marlow Covid-19 vaccination clinic in a block of offices in Marlow, Buckinghamshire.

Picard with his team and volunteers started administering Covid-19 vaccines from January 22, 2021.

He said: “The reason we wanted to do it was because we were in complete lockdown and we had already been participating in the provision of vaccination for flu and we thought we could do this.”

“This would be the way out of the pandemic and now we are seeing it’s having great benefits on the health of the local population.”

More For You

NHS app to boost clinical trials

The focus is on encouraging people from underrepresented groups, including minorities from African and Asian heritage, to sign up for clinical trials.

iStock

Government to use NHS app to boost clinical trials

The government’s 10-Year Health Plan is expected to provide a fillip to clinical trials, and it plans to make use of the NHS App to encourage people to sign up as participants.

People will be able to sign up for the NIHR Be Part of Research service (bepartofresearch.uk) on the NHS App for the trials best suited to their interests and needs.

Keep ReadingShow less
US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less
Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less